Both in Biotechnology
Black Hawk Acquisition vs Estrella Immunopharma
Over the past year BKHA returned −59.8% and ESLA returned −84.0%; their daily moves had a correlation of 0.04.
BKHA −59.8% ESLA −84.0%Growth of $1, one year, split-adjusted
| Metric | BKHA | ESLA |
|---|---|---|
| Price | $4.50 | $0.4101 |
| Market cap | $18.7M | $17.8M |
| Today | −19.21% | −7.53% |
| 1 month | −65.4% | −2.2% |
| 6 months | — | −67.7% |
| Year to date | −60.0% | −73.7% |
| 1 year | — | −82.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | 164.3% | 201.7% |
| Short % of float | 2.6% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).